BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1067 related articles for article (PubMed ID: 9685239)

  • 1. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
    Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
    J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HSV-1 replication and reactivation by the mutation-insensitive transcription inhibitor tetra-O-glycyl-nordihydroguaiaretic acid.
    Park R; Giza PE; Mold DE; Huang RC
    Antiviral Res; 2003 Mar; 58(1):35-45. PubMed ID: 12719005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of esterified alpha-lactalbumin and beta-lactoglobulin against herpes simplex virus type 1. Comparison with the effect of acyclovir and L-polylysines.
    Sitohy M; Billaudel S; Haertlé T; Chobert JM
    J Agric Food Chem; 2007 Dec; 55(25):10214-20. PubMed ID: 17990848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metal complexes of acyclovir and its acetylated derivative on Herpes simplex virus 1 and Herpes simplex virus 2 replication.
    Varadinova T; Vilhelmova N; Badenas F; Terrón A; Fiol J; Garcia-Raso A; Genova P
    Acta Virol; 2005; 49(4):251-60. PubMed ID: 16402682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
    Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
    J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synergistic effects of betulin with acyclovir against herpes simplex viruses.
    Gong Y; Raj KM; Luscombe CA; Gadawski I; Tam T; Chu J; Gibson D; Carlson R; Sacks SL
    Antiviral Res; 2004 Nov; 64(2):127-30. PubMed ID: 15498608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.
    Thi TN; Deback C; Malet I; Bonnafous P; Ait-Arkoub Z; Agut H
    Antiviral Res; 2006 Mar; 69(3):152-7. PubMed ID: 16388859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
    Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
    Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HSV-1 replication and HSV DNA polymerase by the chloroxoquinolinic ribonucleoside 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid and its aglycone.
    Souza TM; De Souza MC; Ferreira VF; Canuto CV; Marques IP; Fontes CF; Frugulhetti IC
    Antiviral Res; 2008 Jan; 77(1):20-7. PubMed ID: 17931712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
    Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
    Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity.
    Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M
    Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activities of methylated nordihydroguaiaretic acids. 1. Synthesis, structure identification, and inhibition of tat-regulated HIV transactivation.
    Hwu JR; Tseng WN; Gnabre J; Giza P; Huang RC
    J Med Chem; 1998 Jul; 41(16):2994-3000. PubMed ID: 9685238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients.
    Matteoli B; Bernardini S; Iuliano R; Parenti S; Freer G; Broccolo F; Baggiani A; Subissi A; Arcamone F; Ceccherini-Nelli L
    Intervirology; 2008; 51(3):166-72. PubMed ID: 18663321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HSV activity of digitoxin and its possible mechanisms.
    Su CT; Hsu JT; Hsieh HP; Lin PH; Chen TC; Kao CL; Lee CN; Chang SY
    Antiviral Res; 2008 Jul; 79(1):62-70. PubMed ID: 18353452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSV-1 infected cell proteins influence tetracycline-regulated transgene expression.
    Herrlinger U; Pechan PA; Jacobs AH; Woiciechowski C; Rainov NG; Fraefel C; Paulus W; Reeves SA
    J Gene Med; 2000; 2(5):379-89. PubMed ID: 11045432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic effects of bis(thiosemicarbazone) compounds and its palladium(II) complexes on herpes simplex virus growth.
    Genova P; Varadinova T; Matesanz AI; Marinova D; Souza P
    Toxicol Appl Pharmacol; 2004 Jun; 197(2):107-12. PubMed ID: 15163546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yatein from Chamaecyparis obtusa suppresses herpes simplex virus type 1 replication in HeLa cells by interruption the immediate-early gene expression.
    Kuo YC; Kuo YH; Lin YL; Tsai WJ
    Antiviral Res; 2006 Jul; 70(3):112-20. PubMed ID: 16540181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Suzuki M; Okuda T; Shiraki K
    Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.